Understanding how certain immune cells develop and remember infections
Chromatin and transcriptional regulatory factors that initiate and stabilize memory CD8 T cell development
This study is looking at how certain immune cells called CD8 T cells become memory T cells that help protect us from infections, focusing on a special protein called Runx3 that helps these cells develop properly, which could lead to better ways to boost our immune memory.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10885043 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which naive CD8 T cells transform into memory T cells that can provide long-lasting immunity against infections. It focuses on the role of a specific transcription factor, Runx3, in regulating the accessibility of DNA regions crucial for T cell development during initial immune responses. By utilizing advanced techniques like mass spectrometry and RNA interference, the study aims to identify key proteins involved in this process, which could lead to improved strategies for enhancing immune memory.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that affect their immune response, particularly those who may benefit from enhanced T cell memory.
Not a fit: Patients with stable immune conditions or those not experiencing infections may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better vaccines and therapies that enhance the immune system's ability to remember and fight off infections.
How similar studies have performed: Previous research has shown promising results in understanding T cell differentiation and memory formation, indicating that this approach has potential for success.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Pipkin, Matthew Eugene — University of Florida
- Study coordinator: Pipkin, Matthew Eugene
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.